TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Problems

Fibroids in pregnancy

Key Statistics

  • 10.7% — Fibroid prevalence, 1ST trimester
  • 48.5% — Caesarean rate with fibroids (vs 13.3%)
  • 35.2% — Miscarriage rate after UAE (vs 16.5%)

Don't-miss facts

  1. MBRRACE 2015: PPH = 2nd commonest cause of direct maternal death; fibroids are a key contributor via mechanical impairment of uterine contractility

  2. Fibroids: caesarean rate 48.5% vs 13.3%; double the risk of placenta praevia; complications more likely if volume

200 cm³ or diameter >5 cm

  1. Ulipristal acetate must be stopped before conception – antenatal exposure: 33% miscarriage, 92% caesarean section in continuing pregnancies

  2. UAE should not be routinely offered pre-conception: ↑miscarriage, ↑caesarean, ↑PPH, and 11% placenta accreta risk

  3. Uterine rupture after myomectomy: laparoscopic 1.2–6.8% vs open 0.4%; wait ≥6 months post-laparoscopic myomectomy before conceiving (Canadian guidance)

  4. At caesarean: incise ≥2 cm from fibroids; classical incision ≥10 cm if needed for cervical fibroids

  5. Caesarean myomectomy is safe and cost-effective – adds only ~15 min operating time, no ↑transfusion/fever risk vs caesarean alone

  6. 70% of fibroids regress by 3–6 months postpartum; less regression with Black ethnicity, progesterone-only contraception, and after miscarriage

Evidence tiers at a glance

Safe: tranexamic acid, paracetamol, opiates, cell salvage

Avoid pre-conception: UPA, GnRH agonists, danazol, aromatase inhibitors, routine UAE

Abbreviation Key

  • MBRRACE — Mothers and Babies: Reducing Risk through Audits
  • ECV — external cephalic version and Confidential Enquiries
  • NSAID — non-steroidal anti-inflammatory drug
  • PPH — postpartum haemorrhage
  • VTE — venous thromboembolism
  • PPROM — preterm prelabour rupture of membranes
  • NEC — necrotising enterocolitis
  • FGR — fetal growth restriction
  • GnRH — gonadotropin-releasing hormone
  • UAE — uterine artery embolisation
  • OR — odds ratio
  • UPA — ulipristal acetate
  • CI — confidence interval
  • MRI — magnetic resonance imaging

Source: Sampat K, Alleemudder DI. Fibroids in pregnancy: management and outcomes. The Obstetrician & Gynaecologist 2018;20:187–195. doi:10.1111/tog.12491

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free